Deep brain stimulation (DBS) products
Medtronic has engineered the most advanced DBS system that is adaptable to your individual needs.
Percept™ family with BrainSense technology†
Only the Medtronic DBS Percept™ family utilizes BrainSense™ technology to capture and record real-time brain signals related to your symptoms. This sensing capability allows your clinician to see your brain activities at the exact time you are experiencing symptoms (even when symptoms occur outside of an office visit). As a result, your stimulation can be personalized and adapted by your clinician to optimize therapy and minimize side effects.
Percept™ PC neurostimulator
Recharge-free
Designed for
People who are looking for all the benefits of the Percept™ family without the need to periodically recharge their neurostimulator.
Size
Features a thinner,‡ curved design.
Battery life
Experience a low maintenance battery with several years of service life (under typical settings) without ever having to recharge.
Charging
With the PC option, the neurostimulator does not require recharging.
Percept™ RC neurostimulator
Rechargeable
Designed for
People who are looking for all the benefits of the Percept™ family with a long-lasting battery, and don't mind periodically recharging their neurostimulator.
Size
Features the smallest and thinnest rechargeable DBS neurostimulator available.§
Battery life
Count on at least 15 years of service life with consistent stimulation and fast recharge performance. Medtronic patented battery technology has less battery fade than other rechargeable devices for a more reliable, long-lasting battery.¶
Charging
Experience rapid recharging from 10% to 90% full charge in less than 1 hour.Ω The typical number of days before needing to recharge can be up to 9 to 12 days.†† If charging daily, recharging can take as little as 15 minutes.‡‡
The Medtronic DBS difference
Medtronic has the most implanted deep brain stimulation (DBS) systems in the world1 and has helped over 180,000 people1 across our indications with our innovative, life-changing therapy.
Medtronic DBS with the Percept™ family is ready to support you through your DBS journey with the most advanced DBS system.
- The only DBS system powered by BrainSense™ technology† that enables clinicians to personalize and adapt therapy to your individual needs.
- Designed small for comfort – with the thinnest recharge-free and rechargeable DBS neurostimulators available.ΩΩ
- Access to 1.5T and 3T MRI with ability for DBS therapy to remain on during an MRI scan.§§ DBS devices from other companies require DBS stimulation to be turned off.2
- Ready for future advancements when software updates become available.
- Choice of recharge-free (PC) or rechargeable (RC) battery options.
More than
180,000
people worldwide1
have received
Medtronic DBS therapy
Why choose Medtronic
Decades of DBS therapy experience
As a global leader in medical technology, we continually seek ways to improve the lives of people. Development of DBS therapy started in 1987 and Medtronic has been a leader in the field ever since. Medtronic DBS therapy for tremor control was approved by the U.S. Food and Drug Administration in 1997.
Leaders in MRI accessibility for DBS patients
Approximately 7 out of 10 DBS-eligible patients with movement disorders may need an MRI within 10 years of receiving their device.3
This is why we developed the first full-body MR Conditional§§ DBS system — which gives you access to this important diagnostic imaging tool should you need it in the future.
A complete system that brings complete benefits
With a complete Medtronic system — lead, extension, and neurostimulator — you get:
Warranty coverage
World-class support
- A system backed by safety and the highest quality standards
Find a doctor
who specializes in
essential tremor treatment.
Use the online directory to find a doctor in your area.
Get more
information.
Sign up to receive information to help make a decision about DBS.
† The sensing feature of the Percept™ PC system and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. Signal may not be present or measurable in patients treated for essential tremor.
‡ As compared to Boston Scientific Vercise Genus™ P16. MP92328632-05 REV B. As compared to St. Jude Medical Infinity™ 5/7 IPG. ARTEN600150429 B.
§ Percept™ RC is over 30% smaller than the Boston Scientific Vercise Genus™ R16. (Medtronic data on file)
¶ The Boston Scientific Vercise Genus™ R16 has a variable 5–15 years of service life, depending on the stimulation settings and conditions (Vercise™ Deep Brain Stimulation Systems Information for Prescribers MP92366224-01 Rev G, accessed December 18, 2023)
Ω For implant depths of up to 2.0 cm under normal conditions.
†† 50th percentile usage will typically have 12 days between required recharges and 80th percentile usage is expected to have 9 days between required recharges (100% to 0%) with sensing OFF.
‡‡ With sensing ON at 80th percentile therapy settings for implant depth of 1 cm.
§§ 
Under specific conditions. Refer to product labeling for full list of conditions: manuals.medtronic.com/mri/region.
ΩΩ As compared to Boston Scientific Vercise Genus™ R16 and Vercise Genus™ P16. MP92328632-05 REV B. As compared to St. Jude Medical Infinity™ 5/7 IPG. ARTEN600150429 B.
Medtronic data on file.
Abbott™ and Boston Scientific™ DBS systems are 1.5T MR conditional and stimulation cannot remain on during an MRI scan. ImageReady™ MRI Guidelines for Boston Scientific Deep Brain Stimulation Systems MP92438760-05 Rev A, accessed December 18, 2023. Abbott MRI Support DBS Full Systems, accessed December 18, 2023.
Falowski S, Safriel Y, Ryan M, Hargens L. The rate of magnetic resonance imaging in patients with deep brain stimulation. Stereotact Funct Neurosurg. 2016; 94:147−153.